← TrialMatch
HomeTrials

ARIADNE Clinical Trial

A prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmu

Condition(s)Persistent Atrial Fibrillation
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryA prospective multi-arm parallel group randomized clinical trial to compare the efficacy of three ablation strategies in patients with persistent atrial fibrillation using using a lattice-tip catheter that can switch between RFA and PFA energy. The incremental benefit of posterior wall isolation (PWI) and mitral isthmus ablation may contribute to greater freedom from atrial fibrillation at twelve months.
Who can participateInclusion Criteria: 1\. Symptomatic PerAF documented by (1a) a physician's note indicating symptoms consistent with AF sustained longer than 7 days but less than 12 months; AND electrocardiographic evidence 2\. . Suitable candidate for catheter ablation. 3\. . Adults aged 18 - 80 years. 4\. . Willing and able to comply with all baseline and follow-up evaluations for the full length of the study. Exclusion Criteria: 1. AF secondary to electrolyte imbalance, thyroid disease, acute alcohol intoxication, or other reversible or non-cardiac cause. 2. Previous left atrial ablation or surgical procedure (including septal closure or left atrial appendage closure). 3. Valvular cardiac surgical/percutaneous procedure (e.g., ventriculotomy, atriotomy, and valve repair or replacement and presence of a
Ages18 Years to 80 Years
SexAll
Lead sponsorStavros E Mountantonakis
LocationsManhasset, New York, United States; New Hyde Park, New York, United States; New York, New York, United States
Start date2025-03-18
NCT IDNCT06747091
Official listinghttps://clinicaltrials.gov/study/NCT06747091

🔍 Search all trials →